ACS Infectious Diseases · 2021 · 13 citations · 35 references
MedicinePharmacokineticsPharmacologyAntimicrobial PharmacologyEnzymologyMolecular PharmacologyAntibacterial PharmacologyEnzyme InhibitionEnzyme KineticsEnzyme TargetsPharmacokinetics Of AntimicrobialsDrug-target Residence KineticsEscherichia ColiPostantibiotic EffectPseudomonas Aeruginosa ResistanceResidence TimeTarget Occupancy Modeling
The translation of time-dependent drug-target occupancy to extended pharmacological activity at low drug concentration depends on factors such as target vulnerability and the rate of target turnover. Previously, we demonstrated that the postantibiotic effect (PAE) caused by inhibitors of bacterial drug targets could be used to assess target vulnerability, and that high levels of target vulnerability coupled with relatively low rates of target resynthesis resulted in a strong correlation between drug-target residence time and the PAE following compound washout. Although the residence time of inhibitors on UDP-3-O-acyl-N-acetylglucosamine deacetylase (LpxC) in Pseudomonas aeruginosa (paLpxC) results in significant PAE, inhibitors of the equivalent enzyme in Escherichia coli (ecLpxC) do not cause a PAE. Hyperactivity of the fatty acid biosynthesis enzyme FabZ or the inclusion of sub-MIC levels of azithromycin lead to the observation of a PAE for three inhibitors of ecLpxC. FabZ hyperactivity has been shown to stabilize ecLpxC, and using mass spectrometry, we demonstrate that the appearance of a PAE can be directly linked to a 3-fold increase in the stability of ecLpxC. These studies substantiate the importance of target turnover in time-dependent drug activity.
35
Dynamics of Protein Turnover, a Missing Dimension in Proteomics
Julie M. Pratt, June Petty, Isabel Riba‐Garcia et al. · Molecular & Cellular Proteomics · 2002 · 404 citations · Full text
Life Sciences, Biochemistry, Biology +17
Postantibiotic Suppression of Bacterial Growth
R. W. Bundtzen, Andreas Gerber, David L. Cohn et al. · Clinical Infectious Diseases · 1981 · 313 citations
Drug–Target Kinetics in Drug Discovery
Peter J. Tonge · ACS Chemical Neuroscience · 2017 · 289 citations · Full text